Literature DB >> 20661690

Clinical value of 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease.

Yoshihiro Nishiyama1, Yuka Yamamoto, Hiroaki Dobashi, Tomohiro Kameda.   

Abstract

Connective tissue diseases represent a heterogeneous group of immunologically mediated inflammatory disorders with a large variety of affected organs other than the lung. (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) is widely used in oncology but may also be valuable in patients with infections or inflammatory disease. The purpose of this article was to assess the clinical value of (18)F-FDG PET in patients with connective tissue disease. Our experience demonstrates that (18)F-FDG PET is a unique imaging technique for assessing the metabolic activity throughout the body in those with a connective tissue disease. The technique appears to be a promising imaging modality for detecting coexistent neoplastic diseases and other autoimmune disorders.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20661690     DOI： 10.1007/s11604-010-0445-x

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN： 1867-1071            Impact factor:   2.374


  24 in total

Review 1.  Clinical manifestations and early diagnosis of Sjögren syndrome.

Authors:  Stuart S Kassan; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2004-06-28

Review 2.  [Current concepts on the physiopathology of adult-onset Still's disease].

Authors:  J B Arlet; D Boutin Le Thi Huong; J Pouchot; J C Piette
Journal:  Rev Med Interne       Date:  2004-12-25       Impact factor: 0.728

3.  Landmark article May 23, 1942: Diffuse collagen disease. Acute disseminated lupus erythematosus and diffuse scleroderma. By Paul Klemperer, Abou D. Pollack and George Baehr.

Authors:  P Klemperer; A D Pollack; G Baehr
Journal:  JAMA       Date:  1984 Mar 23-30       Impact factor: 56.272

4.  (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3.

Authors:  Catherine Beckers; Xavier Jeukens; Clio Ribbens; Béatrice André; Stefaan Marcelis; Philippe Leclercq; Marie-Joëlle Kaiser; Jacqueline Foidart; Roland Hustinx; Michel G Malaise
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-25       Impact factor: 9.236

5.  Clinical PET in Oncology.

Authors:  R Edward Coleman
Journal:  Clin Positron Imaging       Date:  1998-12

6.  A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.

Authors:  Miroslawa Nowak; Jorge A Carrasquillo; Cheryl H Yarboro; Steven L Bacharach; Millie Whatley; Xavier Valencia; Kazuki Takada; Douglas G Brust; Gabor G Illei
Journal:  Arthritis Rheum       Date:  2004-04

Review 7.  Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries.

Authors:  Wengen Chen; Gonca G Bural; Drew A Torigian; Daniel J Rader; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-04       Impact factor: 9.236

8.  2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in systemic lupus erythematosus-associated adenopathy.

Authors:  Geoffrey L Fey; Paul R Jolles; Lenore M Buckley; Gita V Massey
Journal:  Mol Imaging Biol       Date:  2004 Jan-Feb       Impact factor: 3.488

9.  Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.

Authors:  Catherine Beckers; Clio Ribbens; Béatrice André; Stefaan Marcelis; Olivier Kaye; Luc Mathy; Marie-Joëlle Kaiser; Roland Hustinx; Jacqueline Foidart; Michel G Malaise
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

10.  Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis.

Authors:  David W Seldin; Ihsan Habib; Gabriel Soudry
Journal:  Clin Nucl Med       Date:  2007-07       Impact factor: 7.794
View more
  11 in total

1.  18F-FDG PET/CT in patients with adult-onset Still's disease.

Authors:  Meng-Jie Dong; Cai-Qin Wang; Kui Zhao; Guo-Lin Wang; Mei-Ling Sun; Zhen-Feng Liu; Liqin Xu
Journal:  Clin Rheumatol       Date:  2015-02-26       Impact factor: 2.980

Review 2.  Imaging of connective tissue diseases of the head and neck.

Authors:  Ahmed Abdel Khalek Abdel Razek
Journal:  Neuroradiol J       Date:  2016-03-17

Review 3.  Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma.

Authors:  Marta Bueno; Anna Papazoglou; Eleanor Valenzi; Mauricio Rojas; Robert Lafyatis; Ana L Mora
Journal:  Curr Rheumatol Rep       Date:  2020-06-19       Impact factor: 4.592

4.  The Clinical Usefulness of (18)F-FDG PET/CT in Patients with Systemic Autoimmune Disease.

Authors:  Jong-Ryool Oh; Ho-Chun Song; Sae-Ryung Kang; Su-Woong Yoo; Jahae Kim; Ari Chong; Jung-Joon Min; Hee-Seung Bom; Shin-Seok Lee; Yong-Wook Park
Journal:  Nucl Med Mol Imaging       Date:  2011-08-05

5.  Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors.

Authors:  Ubaldo E Martinez-Outschoorn; Zhao Lin; Casey Trimmer; Neal Flomenberg; Chenguang Wang; Stephanos Pavlides; Richard G Pestell; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

6.  PET/CT and inflammatory mediators in systemic sclerosis-associated interstitial lung disease.

Authors:  Andréa L Bastos; Gilda A Ferreira; Marcelo Mamede; Eliane V Mancuzo; Mauro M Teixeira; Flávia P S T Santos; Cid S Ferreira; Ricardo A Correa
Journal:  J Bras Pneumol       Date:  2022-06-06       Impact factor: 2.800

7.  Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Kimiteru Ito; Ryogo Minamimoto; Hiroyuki Yamashita; Setsuko Yoshida; Miyako Morooka; Momoko Okasaki; Akio Mimori; Kazuo Kubota
Journal:  Ann Nucl Med       Date:  2012-12-16       Impact factor: 2.668

8.  Flip-flop phenomenon in systemic sclerosis on fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Kevser Oksuzoglu; Gulsen Ozen; Sabahat Inanir; Rafi Haner Direskeneli
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

9.  18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography can reliably rule-out infection and cancer in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis suspected of disease relapse.

Authors:  Evan C Frary; Søren Hess; Oke Gerke; Helle Laustrup
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

10.  Distinguishing between limited systemic scleroderma-associated pseudo-obstruction and peritoneal dissemination.

Authors:  Susumu Saigusa; Yasuhiro Inoue; Masaki Ohi; Hiroki Imaoka; Ryo Uratani; Minako Kobayashi; Masato Kusunoki
Journal:  Surg Case Rep       Date:  2015-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.